Select Page

Macro Group Publishes Prospectus

Macro Group Pharmaceuticals (MCRO) has released its prospectus ahead of its highly anticipated IPO.

The FRA approved Macro’s prospectus yesterday, January 23rd, 2022, for the listing of 45.8% of the company’s shares on the EGX.